Observationnal • State of Art

ARGOS II

State of Art

48137

Patients enrolled in the program

107

Participating center(s) across the study

Study description

A database study to describe the use of Cureety remote monitoring in the real-world setting in France between Oct. 1st 2019 and March 31st 2026.

Key results

Wide range of patient profiles in terms of age, gender, cancer types and treatments Adopted by all types of HCPs and care centers, private and public, large and small More than 80% of patients satisfies or very satisfied.Distribution of clinical classifications varies according to the treatment type, in line with the expected relative toxicity of treatment types Strong growth in usage since 2019, accelerating with reimbursement start

Research collaboration

Discuss this study with our research team

Questions about methodology, results, or potential collaborations — our team is available to engage with researchers, clinicians and life sciences partners.